RCS - Microsaic Systems - Update on Microsaic's miniaturised technology
28/03/2022 07:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220328:nRSb1555Ga&default-theme=true
RNS Number : 1555G Microsaic Systems plc 28 March 2022
Reach
28 March 2022
Microsaic Systems plc
("Microsaic" or the "Company")
Microsaic miniaturised technology in first UK deployment of COVID-19 sewage
sentinel detection system
Microsaic Systems plc (AIM: MSYS), the developer of micro-engineering
chip-based mass spectrometry equipment, is pleased to note the update by
DeepVerge plc (AIM: DVRG) ("DeepVerge") provided today regarding the first UK
deployment of their Microtox(®)PD pathogen detection system.
While there are no new orders for Microsaic at this stage, Microsaic and
DeepVerge have continued to work closely together to develop further
iterations of the Microtox(®)PD units and on potential upgrades to the
existing Modern Water equipment in miniaturised form.
Gerry Brandon, Executive Chairman of Microsaic commented:
"These successful installations once again exemplify the close working
partnership between DeepVerge and Microsaic, and our aligned approach to the
application of miniaturised but powerful detection technologies in the
environmental sector."
Enquiries:
Microsaic Systems plc +44 (0)734 0055 648
Gerry Brandon Chairman
Singer Capital Markets +44 (0)20 7496 3000
(Nominated Adviser & Joint Broker)
Aubrey Powell / Tom Salvesen / George Tzimas
Turner Pope Investments (TPI) Limited (Broker) +44 (0) 20 3657 0050
Andy Thacker / James Pope
About Microsaic
Microsaic develops and commercialises micro-engineering chip-based mass
spectrometry equipment. Microsaic has a robust patent portfolio in
cutting-edge technology purpose built for "Industry 4.0" which enables
analytical detection and characterisation at the point-of-need, whether within
a human health environment, conventional laboratory setting, or within a
bioprocessing facility for continuous mass spectrometer detection and
monitoring of data at any step in the process workflow, or in frontline
environmental monitoring
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRABKOBPKBKBANB